N-butyl cyanoacrylate was approved by the U.S. FDA on 25/09/2000 as a tissue adhesive to control bleeding of brain arteriovenous malformations.

N-butyl cyanoacrylate is a tissue adhesive solution that controls bleeding in skin wounds, including surgical incisions. It also eliminates the chance of infection and accelerates the wound-healing process. It controls variceal (bleeding from the enlarged or swollen veins) gastrointestinal bleeding. It also fixes hernia meshes (a medical device that supports damaged tissue) in hernia surgery.

N-butyl cyanoacrylate is available as an injection in two different strengths: 0.5ml and 1ml. This injection therapy is given via a catheter (tube) into the brain's blood vessels. Your doctor will decide your most apt dosage based on age, body weight, and physical circumstances.

Common side effects associated with n-butyl cyanoacrylate injection may include skin irritation and a warm sensation at the application site. These effects are generally mild and temporary. It is important to monitor and report any unusual or persistent reactions to your healthcare provider. Adherence to proper usage guidelines and prompt communication with your medical team can help manage and address these common side effects effectively.

Prioritize communication with healthcare providers during n-butyl cyanoacrylate injection therapy. Report adverse reactions promptly, store the injection correctly, attend follow-ups, and participate in treatment decisions. Stay vigilant about side effects, expiration dates, and accidental skin contact. Discuss concerns openly with healthcare professionals, maintain a balanced lifestyle, and follow personalized advice for accurate guidance.

Before n-butyl cyanoacrylate injection therapy, disclose cyanoacrylate allergies and your medical history, including medications. This injection is administered in a hospital by a trained provider; pregnant or breastfeeding individuals should consult their healthcare provider. Safety for those with lung and liver conditions is uncertain, and alcohol interaction is unclear, requiring consultation with a doctor. The impact on driving ability is unknown, necessitating guidance from a healthcare professional.

During n-butyl cyanoacrylate injection therapy, it is crucial to prioritize communication with healthcare providers and promptly report any adverse reactions. Ensure the injection is stored correctly, attend follow-up appointments, and actively participate in treatment decisions. Stay hydrated, understand potential side effects, and be vigilant about expiration dates. 

In case of concerns or alternative treatment preferences, discuss them openly with healthcare professionals. Prioritize holistic well-being maintaining a balanced lifestyle. Emergency preparedness and preventive measures against accidental skin contact are essential. Always rely on personalized advice from healthcare providers for the most accurate guidance.

1. Cerenovus, Inc., Food and Drug Administration (FDA), [Revised on Sep 2000] [Accessed on Nov 2023] https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfpma/pma.cfm?id=p990040
2. Perfectseal, manufacturer, [Accessed on Nov 2023] https://www.perfectseal.com/product/n-butyl-cyanoacrylate-adhesive/
3. Qureshi A, et al., n-Butyl cyanoacrylate adhesive for skin closure of abdominal wounds: preliminary results; Ann R Coll Surg Engl; Published on Nov 1997; Accessed on 16/11/2023; https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2502961/

The drug information on this page is not a substitute for medical advice; it is meant for educational purposes only. For further details, consult your doctor about your medical condition to know if you can receive this treatment.